Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enzyme immunoassay--a new technique for estimating hemoglobin A1c

W G John1, M R Gray, D L Bates

  • 1Department of Clinical Biochemistry, Royal London Hospital, Whitechapel, UK.

Clinical Chemistry
|April 1, 1993
PubMed
Summary

A new enzyme immunoassay method accurately measures hemoglobin A1c (HbA1c) levels. This reliable diagnostic tool shows high precision and correlates well with existing methods for glycohemoglobin estimation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Haemoglobin A<sub>1c</sub> interpretation; more than mean blood glucose to be considered.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Monitoring vitamin D in the patient with melanoma: impact of sun avoidance on vitamin D levels of patients with melanoma at a U.K. tertiary-referral melanoma service.

The British journal of dermatology·2016
Same author

2013 update on the worldwide standardization of the HbA1c measurement.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

Twin-Site ELISAs for fos and myc Oncoproteins Using the AMPAK System.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011.

Diabetic medicine : a journal of the British Diabetic Association·2012

Area of Science:

  • Clinical Chemistry
  • Immunology
  • Biochemistry

Background:

  • Glycated hemoglobin (HbA1c) is a crucial biomarker for long-term glycemic control in diabetes management.
  • Accurate and precise measurement of HbA1c is essential for effective diabetes diagnosis and monitoring.
  • Existing methods for HbA1c determination may have limitations in terms of cost, complexity, or interferences.

Purpose of the Study:

  • To develop and validate a novel enzyme immunoassay (EIA) method for quantifying hemoglobin A1c (HbA1c).
  • To assess the precision, linearity, and correlation of the new EIA method with established glycohemoglobin assays.
  • To establish a reference interval for HbA1c in a nondiabetic population using the developed method.

Main Methods:

  • Utilized a commercially available enzyme immunoassay system based on microtiter plate technology.

Related Experiment Videos

  • Employed an antibody specific to the Amadori product of glucose on hemoglobin's N-terminal beta chain.
  • Evaluated assay performance including within-batch and between-batch precision, linearity, and correlation with established methods.

    • Main Results:

    • The EIA method demonstrated excellent precision (CV 2.3-5.0%) and linearity across the expected HbA1c range.
    • High correlation (r = 0.88-0.98) was observed between the new method and established glycohemoglobin assays.
    • A reference interval of 2.8-4.9% for HbA1c was established in a nondiabetic population.
    • Diabetic individuals showed significantly higher HbA1c percentages (6.86% +/- 2.51%) compared to nondiabetics (3.46% +/- 0.52%).

    Conclusions:

    • The developed enzyme immunoassay provides a precise and reliable method for estimating HbA1c.
    • This method is suitable for routine clinical laboratory use, offering accurate glycohemoglobin measurements.
    • The findings support the utility of this EIA for differentiating between diabetic and nondiabetic individuals based on HbA1c levels.